---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-008245"
form_type: "8-K"
ticker: "LGVN"
cik: "0001721484"
company_name: "Longeveron Inc."
filed_at: "2022-02-17T23:59:59+00:00"
generated_at: "2026-06-27T07:06:11.811048+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Longeveron appoints Todd Girolamo to Board of Directors

## Summary
- Girolamo appointed as Class II Director effective February 15, 2022; term expires at 2023 annual meeting.
- He will serve on the Audit Committee and receive a grant of 5,000 shares of Class A common stock (vesting) plus pro-rated cash retainer.
- Girolamo is Chief Legal Officer and SVP of Corporate Development at Caladrius Biosciences (NASDAQ: CLBS).
- No arrangements or transactions requiring Item 404(a) disclosure were reported.
- Board size unchanged; appointment adds legal, finance, and M&A expertise for Lomecel-B development.

## SEC filing metadata
- accession: 0001213900-22-008245
- form_type: 8-K
- ticker: LGVN
- cik: 0001721484
- company_name: Longeveron Inc.
- filed_at: 2022-02-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1721484/000121390022008245/0001213900-22-008245-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1721484/000121390022008245/ea155885-8k_longeveron.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-008245
- JSON: https://secwatch.observer/filing/0001213900-22-008245.json
- Plain text: https://secwatch.observer/filing/0001213900-22-008245.txt

## Key facts
- Executive change
  Todd C. Girolamo was appointed as Class II Director at Longeveron Inc..
  - Action: appointed
  - Role: Class II Director
  source text: On February 15, 2022, Todd C. Girolamo was appointed to the Board of Directors (the “Board”) of Longeveron Inc. (the “Company”), serving as a Class II Director with his term expiring at the Company’s 2023 annual stockholders’ meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1721484/000121390022008245/0001213900-22-008245-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.